Experts’ Advice for the week of 12 March to 16 March, 2018

By | 12th March 2018

Stock Market Experts’ Advice for the week of 12 March to 16 March, 2018

What you can Buy or Sell? Top 7 stocks from different brokerage houses with their comments.

Swaraj Engines:

Research House: HDFC Securities
Advice: BUY
Market Price Rs.: 1915
1 Year Target Price Rs.: 2468
Potential Upside: 29%

Maintain BUY.
Due to growth visibility, it’s an ideal case for rerating.

With 14% market share, it is one of the biggest tractor engine makers.

Once capex cycle is over, it may come out with buybacks.

Akzo Nobel:

Research House: Kotak Securities
Advice: BUY
Market Price Rs.: 1770
1 Year Target Price Rs.: 2250
Potential Upside: 27%

Initiate BUY.
Trading at 22% discount to peers.

The valuation gap will narrow among Akzo and other players and this will be one of the key triggers for the stock.

You may like this : Get your investment process back on track in a new financial year

Ipca Laboratories:

Research House: Prabhudas Lilladher
Advice: BUY
Market Price Rs.: 666
1 Year Target Price Rs.: 837
Potential Upside: 26%

Initiate BUY.
Unlike peers, Ipca Labs completed exhaustive remediation work, including remodeling of facilities.

So, expect re-approval of the facilities by the USFDA in 2018-19.

Bharat Electronics:

Research House: JP Morgan
Advice: Overweight
Market Price Rs.: 148
1 Year Target Price Rs.: 185
Potential Upside: 25%

Initiate BUY.
Recent stock price weakness, led by weak inflows and earnings miss in the December quarter makes it a buying opportunity.

Aegis Logistics:

Research House: Motilal Oswal
Advice: BUY
Market Price Rs.: 245
1 Year Target Price Rs.: 303
Potential Upside: 294

Initiate BUY.
Despite the jump in market cap over the past decade, there is upside potential as it’s a structural growth story with a clear focus, execution in a niche market and planned expansions.

You might like this : Book Review: Brightest Investment Minds

Apex Frozen Foods:

Research House: Reliance Securities
Advice: BUY
Market Price Rs.: 664
1 Year Target Price Rs.: 818
Potential Upside: 23%

Initiate BUY.
Increasing demand for Indian shrimp in the US and EU.

Commissioning new capacities, improved product mix and high operating leverages will be key growth drivers for the company.

Sun Pharma:

Research House: IIFL
Advice: Reduce
Market Price Rs.: 515
1 Year Target Price Rs.: 500
Potential Upside: -3%

Downgrade to REDUCE.
Downgraded earning per share estimate on account of ongoing challenges in the US business, risk to Levulan’s profits and continued investments in the specialty business.

CMP as on 8-March-2018


Our Blog website :

Follow us on Facebook :

Follow us on YouTube :


My descriptions, videos, presentations are only for educational and information purposes and under no circumstances should be used for making investment decisions. I cannot guarantee the accuracy of any information provided.
The stocks picks are based on my own research and personal views and sometimes are from newspapers, tv channel program, magazines, etc. No part of compensation is or will be directly or indirectly related to the views and recommendations of this research. I have not served as an officer director or employee of company and have not been engaged in market – making activity of the company covered in the research report.
Consult qualified financial advisor before making any investment decision.

Leave a Reply

Your email address will not be published. Required fields are marked *